Exciting new research, partly funded by the U.K. Cystic Fibrosis Trust and the Robert Luff Foundation and announced at…
Articles by Charles Moore
Vertex Pharmaceuticals Incorporated is a global biotechnology company whose corporate mission is to discover, develop and commercialize innovative medicines…
Researchers at Claremont, California-based biotechnology company Synedgen are developing targeted therapies that address complications of cystic fibrosis (CF) on pulmonary…
Boulder, Colorado based Nivalis Therapeutics, Inc. a clinical stage pharmaceutical company focused on treating people with cystic fibrosis (CF),…
The International CF Modifier Consortium led by researchers from the University of North Carolina, the University of Toronto, Johns Hopkins…
Flemington, New Jersey based clinical stage biopharmaceutical company Arno Therapeutics, Inc. has announced data from a preclinical study demonstrating…
Johns Hopkins University Hospital physician and Cystic Fibrosis Foundation Vice President of Therapeutics Development Michael Boyle, M.D., testified on…
Cystic Fibrosis researcher Dr. Joshua R. Stokell, PhD, 36, of Charlotte, NC, passed away on June 8, 2015, due to…
Future Science Group (FSG), a progressive publisher focused on breakthrough medical, biotechnological, and scientific research, has announced publication of…
Dr. Basil Hubbard, an assistant professor of pharmacology in the University of Alberta’s Faculty of Medicine & Dentistry envisions…